ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.

PASG Passage Bio Inc

1.31
-0.03 (-2.24%)
03 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Passage Bio Inc PASG NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
-0.03 -2.24% 1.31 16:16:11
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
1.34 1.30 1.38 1.31 1.34
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
22/4/202406:00GLOBEPassage Bio to Present at Chardan’s 8th Annual Genetic..
05/3/202406:00GLOBEPassage Bio Seeks Pennsylvania College Student Candidates..
04/3/202416:22EDGAR2Form S-8 - Securities to be offered to employees in employee..
04/3/202415:09EDGAR2Form S-3 - Registration statement under Securities Act of..
04/3/202406:15EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
04/3/202406:02EDGAR2Form 8-K - Current report
04/3/202406:00GLOBEPassage Bio Reports Fourth Quarter and Full-Year 2023..
29/2/202415:06EDGAR2Form 8-K - Current report
27/2/202406:00GLOBEPassage Bio to Participate in Upcoming Investor Conferences
14/2/202408:21EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13/2/202418:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202418:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202415:05EDGAR2Form 8-K - Current report
03/1/202415:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202415:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202415:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/12/202315:15EDGAR2Form 8-K - Current report
20/12/202306:05EDGAR2Form 8-K - Current report
20/12/202306:00GLOBEPassage Bio Announces Promising Initial Data From Phase 1/2..
17/11/202315:30GLOBEPassage Bio Announces Inducement Grant Under Nasdaq Listing..
13/11/202306:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/11/202306:00EDGAR2Form 8-K - Current report
13/11/202306:00GLOBEPassage Bio Reports Third Quarter 2023 Financial Results and..
30/10/202306:00GLOBEPassage Bio to Present at Guggenheim’s 5th Annual..
20/10/202315:30GLOBEPassage Bio Announces Inducement Grants Under Nasdaq Listing..
25/9/202306:00GLOBEPassage Bio to Present at Chardan’s 7th Annual Genetic..
01/9/202315:10EDGAR2Form 8-K - Current report
07/8/202306:18EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/8/202306:15GLOBEPassage Bio Reports Second Quarter 2023 Financial Results..
07/8/202306:15EDGAR2Form 8-K - Current report
07/8/202306:00GLOBEPassage Bio Announces Promising Interim Clinical Data from..
01/8/202315:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/8/202306:00GLOBEPassage Bio to Participate in Upcoming Investor Conferences
31/7/202316:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/7/202316:05EDGAR2Form 3 - Initial statement of beneficial ownership of..
31/7/202306:00GLOBEPassage Bio Welcomes Dolan Sondhi, Ph.D. to Board Of..
28/7/202317:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/7/202306:00EDGAR2Form 8-K - Current report
05/6/202306:00GLOBEPassage Bio to Present at Goldman Sachs 44th Annual Global..
11/5/202306:00GLOBEPassage Bio Reports First Quarter 2023 Financial Results and..

Su Consulta Reciente

Delayed Upgrade Clock